Clinical Trial Update: Risk Factors for Aneurysm Rebleeding

View source ↗

Summary

This clinical trial update from Fujian Medical University examines risk factors for rebleeding in aneurysmal subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Snippet

Sponsor: Fujian Medical University | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Status: UNKNOWN